EUR/USD
1.14281
-0.111%
Gold
4132.76
-0.771%
Oil
69.140
0.827%
USD/JPY
161.917
-0.101%
GBP/USD
1.33783
-0.084%
GBP/JPY
216.622
-0.183%
Browse More
English
简体中文
繁體中文
Tiếng Việt
ไทย
Indonesia
Subscribe
Subscribe
Market News
Market Overview
Real-time News
Market Forecasts
Market Insights
Trading Strategy
Trading Research
Thought Leadership
Market Data
Rate Table
Real-time Chart
Calendar
Calendar
Sentiment Indicator
Investment Bank Order
Gold ETF
EIA Crude Oil
Broker
Forex Broker
Stock Broker
Cryptocurrency Broker
Guide
Trading Essentials
Technical Analysis
Trading Strategy
Trading Term
English
English
简体中文
繁體中文
Tiếng Việt
ไทย
Indonesia
Real-time News
Total Energy CEO: Following the events in Hormuz, if we want to export oil from Iraq, we must go through Syria. But the security situation still doesnt allow it.
Kremlin: Russia has achieved a strategic success in controlling Kostyantivka and continues to create buffer zones.
Kremlin: Unfortunately, Ukraine made some confrontational remarks toward Russia ahead of the summit.
On July 7th, Everest Medicines (01952.HK) announced that the board of directors has announced the completion of the exclusive licensing and collaboration agreement with Travele Therapeutics, which the company previously disclosed on June 2nd, 2026. The licensor will receive an upfront payment of US$112 million and is eligible to receive up to US$1.03 billion in development, regulatory, and commercial milestone payments for up to five indications, as well as tiered royalties based on future annual net sales thresholds (percentages ranging from high single digits to double digits).
The French Ministry of Finance has lowered its 2026 economic growth forecast from 0.9% to 0.7%.